Singapore · Biotechnology startup
Singapore · Mirxes
Mirxes is an RNA technology company that develops blood-based miRNA test kits for early disease detection.
Funding reportedLast round: Post-IPO Equity
Follow Mirxes and see its new rounds in your feed.Start following
What company datasets say Mirxes raised
Funding, as reported
Reported in all91.1Min the source's currency
Last roundPost-IPO Equity
Investors listed6
Valuation$600M, Oct 2024
Biotechnology in Singapore
Startups like it
ASLAN PharmaceuticalsSingapore · founded 2010
RVAC Medicines Pte. Ltd.Singapore · founded 2021
Apeiron BioenergySingapore · founded 2007
Eywa Pharmafounded 2015
Curiox BiosystemsSingapore · founded 2008
Aevice HealthSingapore · founded 2016- SCG Cell TherapySingapore · founded 2017
DotBioSingapore · founded 2017
Is this your company?
Add your raise, your deck and your story, and put Mirxes in front of investors. Or tell us what we have wrong.